| 80.56 1.13 (1.42%) | 10-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 101.19  |
1-year : | 107.35 |
| Resists | First : | 86.64 |
Second : | 91.91 |
| Pivot price | 81.82 |
|||
| Supports | First : | 78.11 | Second : | 64.99 |
| MAs | MA(5) : | 81.04 |
MA(20) : | 82.25 |
| MA(100) : | 88.38 |
MA(250) : | 95.52 |
|
| MACD | MACD : | -1.5 |
Signal : | -1.4 |
| %K %D | K(14,3) : | 22.9 |
D(3) : | 34.7 |
| RSI | RSI(14): 41.1  |
|||
| 52-week | High : | 111.44 | Low : | 78.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MMSI ] has closed above bottom band by 30.3%. Bollinger Bands are 18.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 80.94 - 81.25 | 81.25 - 81.6 |
| Low: | 77.66 - 77.99 | 77.99 - 78.37 |
| Close: | 79.93 - 80.47 | 80.47 - 81.1 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Tue, 14 Oct 2025
Earnings call transcript: Merit Medical Q2 2025 sees record margins - Investing.com
Mon, 13 Oct 2025
Will Merit Medical Systems’ (MMSI) CEO Change Reinforce Its Momentum or Signal a Strategic Shift? - simplywall.st
Mon, 13 Oct 2025
Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unveiling a 31% Potential Upside for Investors - DirectorsTalk Interviews
Mon, 13 Oct 2025
Will Merit Medical Systems’ (MMSI) CEO Change Reinforce Its Momentum or Signal a Strategic Shift? - Sahm
Sun, 12 Oct 2025
A Look at Merit Medical Systems's Valuation Following CEO Transition and Leadership Changes - Sahm
Sat, 11 Oct 2025
Merit Medical Systems (NASDAQ:MMSI) Reaches New 1-Year Low - Here's Why - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 59 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 2.3 (%) |
| Held by Institutions | 107.9 (%) |
| Shares Short | 3,680 (K) |
| Shares Short P.Month | 3,090 (K) |
| EPS | 1.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 25.12 |
| Profit Margin | 8.3 % |
| Operating Margin | 12.3 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 8.6 % |
| Qtrly Rev. Growth | 13.1 % |
| Gross Profit (p.s.) | 11.6 |
| Sales Per Share | 24.14 |
| EBITDA (p.s.) | 4.75 |
| Qtrly Earnings Growth | -11.5 % |
| Operating Cash Flow | 240 (M) |
| Levered Free Cash Flow | 191 (M) |
| PE Ratio | 40.89 |
| PEG Ratio | 0 |
| Price to Book value | 3.2 |
| Price to Sales | 3.33 |
| Price to Cash Flow | 19.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|